How many Sustena (estradiol valerate) injections are needed to transition to Trinza (testosterone undecanoate)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Sustenna to Trinza Transition Requirements

You need at least 4 monthly Sustenna injections before transitioning to Trinza. This is the FDA-mandated requirement to ensure adequate stabilization on the monthly formulation before switching to the quarterly extended-release product 1.

Transition Protocol

The FDA label for Trinza explicitly states: "Use INVEGA TRINZA only after the patient has been adequately treated with the 1-month paliperidone palmitate extended-release injectable suspension for at least four months" 1.

Dosing Conversion

When transitioning after 4+ months of Sustenna, initiate Trinza when the next monthly Sustenna dose is scheduled, using the following conversions 1:

  • Sustenna 78 mg → Trinza 273 mg
  • Sustenna 117 mg → Trinza 410 mg
  • Sustenna 156 mg → Trinza 546 mg
  • Sustenna 234 mg → Trinza 819 mg

Note: Conversion from Sustenna 39 mg was not studied and is not recommended 1.

Critical Considerations

The 4-month stabilization period serves multiple purposes:

  • Confirms patient tolerability and response to paliperidone
  • Establishes appropriate dosing before committing to a 3-month formulation
  • Allows for dose adjustments on the more flexible monthly schedule
  • Reduces risk of prolonged exposure to an ineffective or poorly tolerated dose

Administration requirements for Trinza:

  • Must be given every 3 months (quarterly)
  • Requires vigorous shaking for at least 15 seconds (longer than Sustenna)
  • Intramuscular injection only (deltoid or gluteal)
  • Must use the specific thin-wall needles provided in the kit 1

Managing Missed Doses

If transitioning is delayed beyond the scheduled timeframe, specific re-initiation protocols apply based on how long has elapsed since the last injection 1.

Related Questions

Given a serum testosterone of 1281 ng/dL while on testosterone enanthate 100 mg twice weekly, should I decrease the dose to 50 mg twice weekly to lower estradiol levels?
In a male receiving testosterone injections twice weekly with an estradiol level of 99.7 pg/mL, how should the elevated estradiol be managed?
How should I convert a patient taking estradiol 2 mg orally twice daily to an equivalent injectable estradiol regimen?
Should a transgender male (female-to-male) use estrogen cream?
What is the risk of lactation induction in a transgender female taking estradiol 6 mg daily, spironolactone, and micronized progesterone (Prometrium) 100 mg nightly?
Please generate a SOAP note with CPT and ICD‑10 codes for a 41‑year‑old male presenting with a left forearm and elbow injury sustained four days ago while moving a hot tub, currently in a sling, experiencing pain and limited rotation, with a history of type 2 diabetes mellitus and hypertension, no drug allergies, and requiring radiographs and MRI.
What is the recommended dosing schedule for carbamazepine in patients with refractory seizures, including titration, maintenance dose, and monitoring?
What is the appropriate evaluation and management for acquired dermal melanocytic hyperpigmentation?
When can gastrointestinal symptoms improve after discontinuing Latuda (lurasidone), given that it has been 16 days since stopping?
Does topical GHK‑Cu (copper‑binding peptide glycyl‑L‑histidyl‑L‑lysine) improve skin appearance and promote wound healing?
What is the recommended frequency and duration of use for diclofenac gel in an adult?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.